Center for Observational Research (CfOR), Amgen Ltd, Uxbridge, UK.
Science, Aetion, Inc, Boston, Massachusetts, USA.
BMJ Open. 2021 Oct 6;11(10):e052759. doi: 10.1136/bmjopen-2021-052759.
Patients with multiple myeloma (MM) experience significant delays in diagnosis due to non-specific symptomatology. The aim of this study was to characterise the frequency and timing of clinical features in the primary care setting prior to MM diagnosis.
Population-based cohort study.
Electronic health records data of approximately 17 million patients (2006-2016) within the UK Clinical Practice Research Datalink.
Patients aged ≥18 years with newly diagnosed MM (NDMM), no history of solid tumours and ≥2 years registration in a primary care practice prior to MM diagnosis.
Clinical features and symptoms including bone pain, skeletal-related events (SREs), investigation and confirmation of MM diagnostic CRAB criteria (hyperCalcaemia, Renal impairment, Anaemia, Bone lesions) during the 2 years prior to MM diagnosis; time between symptom manifestation and/or relevant investigation and diagnosis of MM.
Among 2646 patients with NDMM, 47.5% had a bone pain record during the 2-year period prior to MM diagnosis, mainly affecting the back. Regardless of baseline bone pain, investigations for serum calcium level were used in 36.4% of patients prior to MM diagnosis, followed by haemoglobin (65.6%) or renal function (74.1%). Median (Q1, Q3) time from first-recorded bone pain to MM diagnosis was 220 (80, 476) days. Median (Q1, Q3) time from first-recorded hypercalcaemia, renal impairment or anaemia to MM diagnosis was 23 (12, 46), 58 (17, 254) and 73 days (28, 232), respectively. An imaging investigation or referral for imaging was recorded for 60.0% of patients with bone pain/SRE and 32% without.
Nearly half of patients diagnosed with NDMM presented with bone pain approximately 7 months prior to MM diagnosis. Investigations to evaluate all CRAB criteria, including targeted imaging, were underused. Early recognition of myeloma clinical features and optimised use of investigations in primary care may potentially expedite MM diagnosis.
多发性骨髓瘤(MM)患者由于症状非特异性而导致诊断存在明显延迟。本研究旨在描述 MM 诊断前初级保健环境中临床特征的发生频率和时间。
基于人群的队列研究。
英国临床实践研究数据链中约 1700 万患者(2006-2016 年)的电子健康记录数据。
年龄≥18 岁、新诊断为 MM(NDMM)、无实体瘤病史且在 MM 诊断前≥2 年在初级保健机构登记的患者。
在 MM 诊断前的 2 年内,包括骨痛、骨骼相关事件(SRE)、MM 诊断的 CRAB 标准(高钙血症、肾功能损害、贫血、骨病变)的检查和确认在内的临床特征和症状;症状表现和/或相关检查与 MM 诊断之间的时间间隔。
在 2646 例 NDMM 患者中,47.5%在 MM 诊断前 2 年内有骨痛记录,主要影响背部。无论基线是否存在骨痛,在 MM 诊断前,有 36.4%的患者进行了血钙水平检查,其次是血红蛋白(65.6%)或肾功能(74.1%)检查。首次记录骨痛至 MM 诊断的中位(Q1,Q3)时间为 220(80,476)天。首次记录高钙血症、肾功能损害或贫血至 MM 诊断的中位(Q1,Q3)时间分别为 23(12,46)、58(17,254)和 73 天(28,232)。有骨痛/SRE 的患者中,有 60.0%进行了影像学检查或影像学转诊,而无骨痛/SRE 的患者中这一比例为 32%。
约有一半的 NDMM 患者在 MM 诊断前约 7 个月出现骨痛。用于评估所有 CRAB 标准的检查,包括靶向影像学检查,使用不足。在初级保健中早期识别骨髓瘤的临床特征并优化检查的使用,可能有助于加快 MM 的诊断。